Acceleron Pharma reported $5.56B in Market Capitalization for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 154.58B 18.45B
Acceleron Pharma XLRN:US $ 5.56B 768.9M
Akebia Therapeutics AKBA:US $ 354.54M 1.56B
Alexion Pharmaceuticals ALXN:US $ 2.48B 484.33M
Amgen AMGN:US $ 13.87B 1.96B
Arena Pharmaceuticals ARNA:US $ 3.56B 1.45B
Bayer BAYN:GR 6.46B 1.27B
Biomarin Pharmaceutical BMRN:US $ 2.23B 706.84M
Bluebird Bio BLUE:US $ 403.32M 147.73M
Clovis Oncology CLVS:US $ 593.45M 126.32M
Dicerna Pharmaceuticals DRNA:US $ 1.34B 537.96M
Eli Lilly And LLY:US $ 15.7B 2.43B
Exelixis EXEL:US $ 7.28B 2.02B
Gilead Sciences GILD:US $ 9.65B 238.75M
GlaxoSmithKline GSK:LN 8.21B 612.45M
Johnson & Johnson JNJ:US $ 391974.76M 21471.73M
Karyopharm Therapeutics KPTI:US $ 1.38B 19.22M
Mirati Therapeutics MRTX:US $ 3.34B 1.74B
Neurocrine Biosciences NBIX:US $ 11.33B 3.3B
Novartis NOVN:VX 203.34B 1.52B
Pfizer PFE:US $ 181643.06M 568.13M
Ptc Therapeutics PTCT:US $ 323.32M 43.91M
Puma Biotechnology PBYI:US $ 410.57M 78.87M
Regeneron Pharmaceuticals REGN:US $ 6.39B 1.01B
Rigel Pharmaceuticals RIGL:US $ 309.12M 46.15M
Sangamo Biosciences SGMO:US $ 1.26B 522.18M
Tg Therapeutics TGTX:US $ 2.34B 1.26B
Ultragenyx Pharmaceutical RARE:US $ 467.36M 210.16M
United Therapeutics UTHR:US $ 532.55M 115.35M
Vertex Pharmaceuticals VRTX:US $ 7.53B 1.36B